BRAINSTORM CELL THERAPEUTICS INC. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Dec 16, 2015
Insider Transaction Report
Form 4
Friedman Mordechai
Director
Transactions
- Sale
Common Stock
2015-12-14$2.57/sh−5,000$12,850→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2015-12-14−5,000→ 11,666 totalExercise: $0.75Exp: 2024-08-15→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2015-12-14$0.75/sh+5,000$3,750→ 5,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.56 to $2.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The option, representing a right to purchase a total of 16,666 shares of common stock of the Issuer, became vested and exercisable in 12 consecutive, equal monthly installments commencing on September 15, 2014 and fully vested and exercisable on August 15, 2015.